Analysts expect International Business Machines Corporation (NYSE:IBM) to report $2.70 EPS on October, 15.They anticipate $0.72 EPS change or 21.05% from last quarter’s $3.42 EPS. IBM’s profit would be $2.39 billion giving it 13.30 P/E if the $2.70 EPS is correct. After having $3.17 EPS previously, International Business Machines Corporation’s analysts see -14.83% EPS growth. The stock increased 0.03% or $0.05 during the last trading session, reaching $143.67. About 2.06 million shares traded. International Business Machines Corporation (NYSE:IBM) has risen 1.89% since September 15, 2018 and is uptrending. It has outperformed by 1.89% the S&P500. Some Historical IBM News: 26/04/2018 – WhiteSource Launches Contextual Pattern Matching Engine, Supporting Over 200 Programming Languages; 15/05/2018 – Veridium to Use IBM Blockchain Technology to Create Social and Environmental Impact Tokens; 20/03/2018 – International Business Machines Corp: Doc re Form 8-K; 10/05/2018 – IBM Announces Collaboration with North Carolina State University to Accelerate Quantum Computing; 11/04/2018 – Global Financial Analytics Market Report 2017-2021 with Key Players IBM, Microsoft, Oracle and SAP Dominating – ResearchAndMarkets.com; 12/03/2018 – Buying IBM, Amazon, Selling DowDuPont, AT&T — Barrons.com; 17/04/2018 – IBM Ended 1Q With $13.2 Billion of Cash on Hand; 21/03/2018 – Datameer Partners with IBM in New Data Science and Machine Learning Platform; 18/04/2018 – SiliconANGLE: IBM brings two key open-source developer tools together in its latest cloud service; 17/04/2018 – IBM Expects FY18 Operating EPS of at Least $13.80
Eminence Capital Lp decreased Thermo Fisher Scientific Inc (TMO) stake by 38.76% reported in 2019Q2 SEC filing. Eminence Capital Lp sold 226,265 shares as Thermo Fisher Scientific Inc (TMO)’s stock rose 0.43%. The Eminence Capital Lp holds 357,562 shares with $105.01 million value, down from 583,827 last quarter. Thermo Fisher Scientific Inc now has $119.20B valuation. The stock increased 0.91% or $2.68 during the last trading session, reaching $297.65. About 1.05M shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 20.35% since September 15, 2018 and is uptrending. It has outperformed by 20.35% the S&P500. Some Historical TMO News: 16/04/2018 – Thermo Fisher Presenting at Conference Tomorrow; 01/05/2018 – Thermo Fisher Will Retain Global Commercialization Rights for Oncomine Dx Target Test; 17/04/2018 – Thermo Fisher Scientific Showcases Bioprocessing Workflow Solutions at INTERPHEX; 03/04/2018 – TMO: RAPID MYCOPLASMA TESTING METHOD ACCEPTED BY REGULATORS FOR; 28/03/2018 – BIOCEPT, THERMO FISHER SCIENTIFIC ANNOUNCE PACT; 25/04/2018 – THERMO FISHER 1Q REV. $5.85B, EST. $5.63B; 25/04/2018 – Thermo Fisher 1Q EPS $1.43; 27/04/2018 – THERMO FISHER, LEICA IN PACT FOR CRYO-TOMOGRAPHY WORKFLOW; 11/04/2018 – MUDRICK CAPITAL MANAGEMENT SAYS IT WOULD NOT SUPPORT ANY OVERTURE BY GLOBALSTAR TO SEEK ADDITIONAL FINANCING FROM CONTROLLING SHAREHOLDER THERMO COMPANIES; 07/05/2018 – New Thermo Scientific Prisma SEM Combines Performance and Versatility
Among 7 analysts covering Thermo Fisher (NYSE:TMO), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Thermo Fisher has $32100 highest and $288 lowest target. $307’s average target is 3.14% above currents $297.65 stock price. Thermo Fisher had 13 analyst reports since March 18, 2019 according to SRatingsIntel. Argus Research maintained the shares of TMO in report on Wednesday, May 1 with “Buy” rating. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Buy” rating by Barclays Capital on Monday, March 18. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Buy” rating by Needham on Thursday, July 25. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Outperform” rating by Robert W. Baird on Tuesday, March 26. BTIG Research maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Tuesday, March 26. BTIG Research has “Buy” rating and $310 target. The rating was maintained by Deutsche Bank on Friday, March 22 with “Buy”. The firm has “Buy” rating given on Monday, March 25 by UBS. On Thursday, May 23 the stock rating was maintained by UBS with “Buy”. The firm has “Buy” rating given on Tuesday, July 16 by Needham.
Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on October, 23. They expect $2.88 earnings per share, up 9.92% or $0.26 from last year’s $2.62 per share. TMO’s profit will be $1.15B for 25.84 P/E if the $2.88 EPS becomes a reality. After $3.04 actual earnings per share reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts -5.26% negative EPS growth.
More notable recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Finance.Yahoo.com which released: “These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well – Yahoo Finance” on August 27, 2019, also Streetinsider.com with their article: “Thermo Fisher Scientific (TMO) Reports Election of Debora Spar to Board – StreetInsider.com” published on September 05, 2019, Finance.Yahoo.com published: “Medtronic, Other Medtech Providers Could Face Additional Tariffs – Yahoo Finance” on September 03, 2019. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) were released by: Seekingalpha.com and their article: “Thermo Fisher to develop companion diagnostic for Lilly’s selpercatinib – Seeking Alpha” published on September 09, 2019 as well as Finance.Yahoo.com‘s news article titled: “Do Thermo Fisher Scientific’s (NYSE:TMO) Earnings Warrant Your Attention? – Yahoo Finance” with publication date: June 17, 2019.
Eminence Capital Lp increased American Express Co (NYSE:AXP) stake by 8,294 shares to 296,515 valued at $36.60 million in 2019Q2. It also upped Pg&E Corp (NYSE:PCG) stake by 2.23M shares and now owns 7.97M shares. Fidelity Natl Information Sv (NYSE:FIS) was raised too.
Investors sentiment increased to 1.06 in 2019 Q2. Its up 0.10, from 0.96 in 2019Q1. It is positive, as 35 investors sold TMO shares while 429 reduced holdings. 121 funds opened positions while 373 raised stakes. 338.08 million shares or 0.28% more from 337.12 million shares in 2019Q1 were reported. Rafferty Asset Mngmt Ltd Com reported 0% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Guggenheim Ltd holds 90,313 shares or 0.22% of its portfolio. Botty Lc stated it has 15,934 shares. Coastline Trust Co accumulated 24,850 shares. Eaton Vance Management reported 0.32% in Thermo Fisher Scientific Inc. (NYSE:TMO). Homrich Berg stated it has 0.05% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). 57,673 were accumulated by Granite Limited Liability Co. Savant Capital Limited Liability Corporation has invested 0.1% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Hemenway Trust Llc owns 3,259 shares for 0.15% of their portfolio. Kbc Gru Nv reported 263,947 shares stake. Agf Investments accumulated 143,382 shares. Hwg Hldgs LP reported 0.03% stake. New York-based Howe & Rusling Inc has invested 0.01% in Thermo Fisher Scientific Inc. (NYSE:TMO). Napier Park Glob (Us) Lp accumulated 9,000 shares. Regent Inv Limited Liability Co holds 0.77% or 8,085 shares.
International Business Machines Corporation provides information technology services and products worldwide. The company has market cap of $127.27 billion. The Company’s Cognitive Solutions segment includes Watson, a cognitive computing platform that interacts in natural language, processes big data, and learns from interactions with people and computers. It has a 14.83 P/E ratio. The companyÂ’s Cognitive Solutions segment also offers data and analytics solutions, including analytics and data management platforms, cloud data services, enterprise social software, talent management solutions, and solutions tailored by industry; and transaction processing software that runs mission-critical systems in banking, airlines, and retail industries.
Among 9 analysts covering Int`l Business Machines (NYSE:IBM), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 56% are positive. Int`l Business Machines has $17500 highest and $140 lowest target. $158.56’s average target is 10.36% above currents $143.67 stock price. Int`l Business Machines had 11 analyst reports since March 19, 2019 according to SRatingsIntel. As per Thursday, July 18, the company rating was maintained by JP Morgan. The firm has “Buy” rating by Nomura given on Thursday, July 18. The firm has “Buy” rating given on Monday, August 5 by Bank of America. BMO Capital Markets maintained International Business Machines Corporation (NYSE:IBM) on Wednesday, April 17 with “Market Perform” rating. On Wednesday, April 17 the stock rating was maintained by Citigroup with “Neutral”. Wells Fargo maintained International Business Machines Corporation (NYSE:IBM) on Tuesday, August 6 with “Market Perform” rating. The stock of International Business Machines Corporation (NYSE:IBM) has “Overweight” rating given on Thursday, August 1 by Morgan Stanley. The rating was maintained by Nomura on Monday, August 5 with “Buy”.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.
.(tagsToTranslate)International Business Machines Corporation(t)International Business Machines Corporation – (NYSE:IBM)(t)NYSE:IBM(t)Earnings(t)Forecast(t)Revenue(t)Earnings Guidance(t)Thermo Fisher Scientific Inc.(t)Thermo Fisher Scientific Inc. – (NYSE:TMO)(t)NYSE:TMO(t)Stock News(t)13F(t)Insitutional Ownership Change
This is a syndicated post. Read the original post at Source link .